Expression of RELMβ in non-small cell lung cancer and the its relationship with clinicopathological features
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective:This study aimed to detect the expression of resistin-like molecule beta (RELMβ)in human non-small cell lung cancer (NSCLC) and its relationship with clinicopathological characteristics. Methods: We detected the expression levels of RELM β in 103 NSCLC tissues and the same patients’ adjacent noncancerous tissues (including 65 with paired lymph node metastases) by reverse transcription polymerase chain reaction (RT-PCR) and Western blot, and then analyzed their correlation with clinical pathological parameters. Results: RT-PCR and Western blot showed that the expression level of RELMβ in NSCLC tissues was significantly higher than that in noncancerous tissues. Compared with adjacent noncancerous tissues, the mRNA and protein expression levels of RELM β were significantly increased in lung cancer (23.33%,P < 0.05). The high expression of RELM β was closely associated with the degree of differentiation, TNM staging and lymph node metastasis (P < 0.05). Conclusion: The positive expression of RELM β is associated with clinical pathological parameters of NSCLC. RELM β may promote tumor progression.

    Reference
    Related
    Cited by
Get Citation

吕 叶,茅卫东,苏 筠,沈孝兵,姜 藻.抵抗素样分子β在非小细胞肺癌中的表达及其与临床病理特征的关系[J].南京医科大学学报(自然科学版英文版),2015,(6):823-826.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 19,2015
  • Online: June 08,2015
Article QR Code